Psychiatry and Neurology, Neurology · Chicago, IL
NPI
1538555099
Since 2015
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1460 N Halsted St Ste 501
Chicago, IL, 60642
Phone (847) 618-3590
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
6,026 services
Medicare patients, 2024
154
Average age 69
Drug cost, 2024
$1.0M
2,082 prescriptions
Company payments, 2025
$47.6
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zilfah Younus was code 99213 (office e&m - established), 100 times for 74 patients. In total Zilfah Younus billed 6,026 services in 18 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 100 | 74 | $64.96 | $6,496 |
| 64405 Musculoskeletal | Office | 52 | 22 | $41.47 | $2,157 |
| 64450 Musculoskeletal | Office | 52 | 22 | $60.40 | $3,141 |
| 64400 Musculoskeletal | Office | 45 | 15 | $89.31 | $4,019 |
| 99212 Office E&M - Established | Office | 33 | 27 | $34.25 | $1,130 |
| 99215 Office E&M - Established | Office | 32 | 31 | $119.96 | $3,839 |
| 99204 Office E&M - New | Office | 26 | 26 | $104.04 | $2,705 |
| 99214 Office E&M - Established | Office | 20 | 17 | $102.75 | $2,055 |
| 99205 Office E&M - New | Office | 12 | 12 | $146.50 | $1,758 |
By year: 2022 $42K for 2,802 services; 2023 $47K for 4,206 services; 2024 $59K for 6,026 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zilfah Younus prescribed most often to Medicare patients was Gabapentin, with 298 prescriptions and refills. In total Zilfah Younus wrote 2,082 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 298 | 433 | 80 | $3,187 |
| Ubrelvy Ubrogepant | 268 | 268 | 62 | $419K |
| Topiramate Generic | 168 | 333 | 48 | $1,443 |
| Qulipta Atogepant | 148 | 179 | 32 | $199K |
| Aimovig Autoinjector Erenumab-Aooe | 108 | 108 | 12 | $81K |
| Cyclobenzaprine Hcl Generic | 92 | 153 | 30 | $849 |
| Emgality Pen Galcanezumab-Gnlm | 85 | 96 | 15 | $69K |
| Nurtec Odt Rimegepant Sulfate | 83 | 90 | 23 | $126K |
| Tizanidine Hcl Generic | 81 | 144 | 25 | $957 |
| Memantine Hcl Generic | 69 | 91 | 20 | $1,531 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 63 | 72 | 11 | $52K |
| Rizatriptan Rizatriptan Benzoate | 59 | 69 | 19 | $1,076 |
| Carbamazepine Er Carbamazepine | 48 | 70 | Under 11 | $3,132 |
| Amitriptyline Hcl Generic | 47 | 79 | 12 | $964 |
| Oxcarbazepine Generic | 36 | 61 | 11 | $1,070 |
Brand drugs: - claims; generic drugs: 1,265 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zilfah Younus $47.6 ($47.6 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $32.84.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.